Museveni applauds Dr. Magoola for securing U.S Patent for Cancer treatment
Abstract: MicroRNAs (miRNAs) maintain cellular homeostasis by blocking mRNAs by binding with them to fine-tune the expression of genes across numerous biological pathways.
News
Dei BioPharma Founder Dr. Magoola wins prestigious Molecular Biologist Award for his mRNA cutting edge vaccines research
Dr. Matthias Magoola Recognized at International Molecular Biologist Awards for Vaccine Research KAMPALA – Recognition for Groundbreaking Work in mRNA and Therapeutic Proteins Dr. Matthias Magoola, Founder and Managing Director...
MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products—A Prospective Analysis
PUBLICATION BY DR. MATTHIAS MAGOOLA, CHEMIST Abstract MicroRNAs (miRNAs) play a crucial role in maintaining cellular homeostasis by binding to messenger RNAs (mRNAs) and fine-tuning gene expression across various biological...
We are hiring
Job Application Instructions – Dei BioPharma Ltd How to Apply:Applications should be sent via email to recruitment@deibiopharma.com with the JOB TITLE clearly stated in the subject line. Response Time:Successful candidates...
Parliament’s Health Committee urges Dei BioPharma to save Uganda from emerging tropical diseases
MPs Urge Dei Biopharma to Accelerate Production of Life-Saving Medicines KAMPALA, September 29, 2024 – Members of Parliament on the Health Committee have urged Dei Biopharma Vaccines Manufacturing Plant to...
Opposition MPs impressed by progress at Dei BioPharma’s manufacturing plant
Opposition Leader Joel Ssenyonyi Visits Dei BioPharma Facility in Matugga MATUGGA, September 19, 2024 – The sun shone brightly over the Dei BioPharma drugs and vaccines manufacturing facility, casting a...